Through years of research into Particle-Enhanced Turbidimetric Immunoassays (PETIA), production processes and raw material specifications, including nanoparticle qualities and antibody production, we have developed our own proprietary antibody and nanoparticle-based technology. This enables us to develop highly sensitive clinical chemistry immunoassays.
Applying this technology to our product pipelines allows us to develop reagents for biomarkers that are currently measured using separation-based techniques, creating both time and financial savings in the healthcare industry.
At Gentian, we continuously invest in research and development to offer relevant and innovative immunoassays. As a manufacturer for both industry partners and end users, we are adaptable to collaborate in all phases of research and product development. By collaborating with Gentian, our partners can increase their test portfolio without an additional R&D infrastructure. All research, development and manufacturing are performed in-house at our HQ in Norway.
We aim to launch products available for all major clinical chemistry platforms currently on the market. This means that Gentian’s immunoassays can be added to your laboratory test menu without additional investment in instrumentation.
The Gentian Cystatin C Immunoassay is available for a wide range of clinical analysers with high inter instrument accuracy.
The Gentian GCAL® Calprotectin Immunoassay measures calprotectin in plasma and serum in the assessment of inflammation and severe infection.
The Gentian Canine CRP Immunoassay is a PETIA for quantitative analysis of CRP using canine specific antibodies.
Gentian’s assays incorporate immunoparticles that have been manufactured with avian antibodies. Phylogenetic differences between chickens and humans ensure minimal cross-reactivity of antibodies against rheumatoid factor and proteins of the complement system. As a result, Gentian’s immunoparticles provide both increased sensitivity and decreased background signal when used in turbidimetric assays.
10 minutes to result
Contact us to discuss diagnostic efficiency, validation or business opportunities.
Use the form below or send us an email to firstname.lastname@example.org.